Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by jfm1330on Feb 05, 2021 12:01pm
80 Views
Post# 32484385

RE:RE:RE:RE:RE:Nomination

RE:RE:RE:RE:RE:NominationSo Cytodyn is now the model company to emulate??? My god.... PTSD is strong here.


scarlet1967 wrote: CYDY let investors submit questions online so abusive comments won't be addressed and I agree the CC whether related to earnings or material events would be much more informative if they spend some time answering retail investors questions. 
Wino115 wrote: I would love to do that and suggested that to them when some of the sell siders dropped out. It seems to me that if you can have a dozen or so verified institutional holders, let them ask Q's too.  I wouldn't be, but I have friends that would be and SPCEO sure would be.  They used to allow buy-siders to ask questions, but a few angry and disruptive ones ruined it for everyone.


palinc2000 wrote:

Questions from investors are frequently allowed during Investors Day and it seems to me that having a representative of a Fund holding more than 6 million shares and an investor with your background  would  help not only other investors but also the Company....They could make whatever rules they want

 

Wino115 wrote: They've never let anyone other than sell-side analysts ask questions. I don't think that will change anytime soon and seems to be standard now given some of the crazy histrionics past calls on other controversial stocks had. I guess the lawyers have just decided it's better to shut it off for the general public. Only guys like Cytodyn let anyone ask a question, but that's because no sell side would associate with them.
 

 

palinc2000 wrote: I hereby nominate Spceo1 and Wino as representatives pf posters on this MB to ask questions during the Theratech 's CC s 
All those in favor please vote

PS Of course I presume that both nominees are willing to act on our behalf

 

 

 




<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse